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Lipid peroxidation is not the underlying cause of renal injury in
hyperoxaluric rats
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Lipid peroxidation is not the underlying cause of renal injury
in hyperoxaluric rats.
Background. Hyperoxaluria is a major risk factor of cal-
cium oxalate stone disease and renal injury is thought to be
a significant initiating event. However, the relationship among
oxidative stress, renal tubule injury and hyperoxaluria in the
progression of nephrolithiasis is unclear, especially in animal
models. In the current study, we assess the role of oxidative
stress in renal tubular damage in a rat model of chronic hyper-
oxaluria (HYP) and chronic renal failure induced by hyperox-
aluria (HRF) compared to control rats.
Methods. Urinary excretion of renal tubular enzymes, in-
cluding lactate dehydrogenase (LDH), alkaline phosphatase
(AP), N-acetyl-b-D-glucosaminidase (NAG), and a- and l-
glutathione-S-transferase (a-GST and l-GST, respectively) was
quantified in four groups of Sprague-Dawley rats. The study
included normal controls, those made hyperoxaluric with ethy-
lene glycol administration (HYP), unilateral nephrectomized
controls, and unilateral nephrectomized rats administered ethy-
lene glycol (HRF). Levels of catalase, superoxide dismutase
(SOD), glutathione peroxidase (GP), and glutathione trans-
ferase (GST) in the renal cortex were measured after 4 weeks
and lipid peroxidation was assessed by measuring 8-isoprostane
in the urine and lipid hydroperoxide in the renal cortex.
Results. Urinary excretion of NAG, AP, and LDH was ele-
vated after 2 and 4 weeks in the HYP and HRF groups. Urinary
levels of l-GST, a marker of distal tubule damage, were elevated
in HRF rats after 4 weeks. a-GST levels were similar between
control and HYP rats but were lower in HRF rats. Levels of cata-
lase, SOD, GP, and GST in the renal cortex were similar among
control, HYP, and unilateral nephrectomized control rats, but
were attenuated in the HRF rats after 4 weeks. Renal cortical
content of lipid hydroperoxide and urinary 8-isoprostane levels
were similar among all groups after 4 weeks.
Conclusion. Ethylene glycol-induced hyperoxaluria in
Sprague-Dawley rats is accompanied by enzymuria, which is
suggestive of renal tubular damage. The antioxidant capacity of
the renal cortex in HYP rats is similar to that of control rats af-
ter 4 weeks of treatment; however, this capacity is significantly
attenuated in rats that are in renal failure induced by hyper-
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oxaluria, although significant lipid peroxidation is not evident.
These results suggest that lipid peroxidation is not the underly-
ing cause of renal injury in hyperoxaluric rats.
Hyperoxaluria is a major risk factor of calcium oxalate
stone disease with some 30% of the stone-forming pop-
ulation exhibiting this clinical condition [1, 2]. The pro-
gression from hyperoxaluria to nephrolithiasis is certainly
multifaceted and renal tubular injury is thought to be cen-
tral to the process [3–8]. Many have demonstrated that
oxalate ions as well as calcium oxalate crystals promote
renal tubular injury (manifested in vivo as an increase
in urinary enzymes) and much recent attention has fo-
cused on the generation of free radicals as a potential
mechanism by which this injury occurs [9–14]. Indeed,
many current models of calcium oxalate stone disease
suggest that the generation of reactive oxygen species
(ROS) and subsequent lipid peroxidation is an integral
part of the process [3, 6, 15]. However, the relationship
among oxalate-induced renal injury, oxidative stress and
lipid peroxidation is, at best, only correlative in humans
[16]. Moreover, experimental (in vivo) models of hyper-
oxaluria have not fully established such a relationship,
especially in the later stages of nephrolithiasis, since the
production of free radicals in both urine and blood does
not correlate well with the excretion of renal injury mark-
ers such as b-galactosidase, neutral endopeptidase, and
N-acetyl-b-D-glucosaminidase (NAG) [12]. In contrast,
there are in vitro data that suggest a role for free radical
involvement in calcium oxalate stone disease as the pro-
vision of free radical scavengers to the culture medium
blocks the nephrotoxic effects of oxalate and calcium ox-
alate [9, 14, 15, 17].
An increased production of ROS in response to an in-
sult, such as hyperoxaluria, triggers the kidney to adapt to
this insult by up-regulating the antioxidant defense sys-
tems such as superoxide dismutase (SOD), catalase, glu-
tathione peroxidase (GP), and glutathione (GSH). When
the production of ROS overwhelms the antioxidant re-
sponse or when antioxidant levels are depleted due to a
chronic pro-oxidant insult, the cells are under “oxidative
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stress” [18]. As a consequence, oxidative damage to lipids
(lipid peroxidation), as well as other biomolecules, may
ensue. Many have presumed that lipid peroxidation is the
molecular mechanism by which oxalate and/or calcium
oxalate promote renal injury in hyperoxaluric rats [5, 8,
10], but these conclusions have been largely drawn from
assay results which indirectly measure lipid peroxidation
via malondialdehyde (MDA) and/or thiobarbituric acid
reaction substance (TBARS) and are of questionable va-
lidity [18–21]. We have reevaluated the role of lipid perox-
idation in the ethylene glycol–induced hyperoxaluric rat
and have attempted to correlate renal injury with lipid
peroxidation using both direct measurement of lipid hy-
droperoxide in the renal cortex and urinary excretion of
8-isoprostane. Our findings suggest that lipid peroxida-
tion is not the underlying cause of renal injury in hyperox-
aluric rats. We make this conclusion based on the fact that
several markers of renal injury [NAG, AP, and lactate de-
hydrogenase (LDH)] were elevated in the urine without
coincident changes in renal antioxidant capacity, renal
content of lipid hydroperoxides, or urinary excretion of 8-
isoprostane. Consequently, no significant correlation was
observed between renal injury and lipid peroxidation.
METHODS
Animals
A total of 68 male Sprague-Dawley rats (275 to 300 g)
were utilized in the current study. The rats had free ac-
cess to Purina Rat Chow 5001 during the entire course of
the study and all experimental protocols were conducted
in accordance with the guidelines of the University of
Florida Institutional Animal Care and Use Committee
and the National Institutes of Health (NIH) Guide for
the Care and Use of Laboratory Animals.
Experimental protocols
Hyperoxaluria (HYP) (N = 17) was induced by pro-
viding free access to drinking water that contained 0.75%
(vol/vol) ethylene glycol for a period of 4 weeks [22]. Rats
provided free access to normal drinking water served as
controls (N = 17). Hyperoxaluria-induced chronic renal
failure (HRF) (N = 17) was generated by providing uni-
laterally nephrectomized rats free access to drinking wa-
ter that contained 0.75% (vol/vol) ethylene glycol for a
period of 4 weeks as previously described [23]. Unilat-
eral nephrectomized rats (N = 17) provided free access
to normal drinking water served as a control group.
Unilateral nephrectomy
In order to produce oxalate-induced chronic renal
failure, a unilateral nephrectomy was performed on 34
rats. Briefly, a surgical plane of anesthesia was induced
by an intraperitoneal injection of sodium pentobarbital
(40 mg/kg body weight). A small dorsal incision, approxi-
mately 1.5 to 2 cm, was made and the kidney was exposed
through the dorsal incision, decapsulated, and the renal
vasculature ligated before excision of the renal mass. The
flanking musculature was sutured and the skin was closed
using AutoclipTM wound clips (Becton Dickinson, Sparks,
MD, USA). Prior to initiating the treatments, all rats that
underwent surgery were given 1 week to recover before
initiating ethylene glycol treatment.
Urine collection
Two weeks after the initiation of treatment and on
the penultimate day of the study, rats were placed in
metabolic cages and urine was collected for a 24-hour
period in 20 lL of 20% sodium azide as a preserva-
tive. Debris was sedimented by low speed centrifugation
and an aliquot of urine was acidified by the addition
of 3 N HCl (∼1 mL/5 mL urine volume) for the de-
termination of urinary oxalate and creatinine. An addi-
tional 500 lL aliquot of unacidified urine was removed
and diluted with 125 lL of rat urine stabilizing buffer
(Biotrin International, Dublin, Ireland) for measurement
of l-glutathione-S-transferase (l-GST) (GSTYb1) and
a-GST. The remaining urine was frozen at −20◦C and
used for the determination of AP, LDH, NAG, and 8-
isoprostane.
Biochemical assays
Urinary oxalate levels were quantified with a com-
mercially available kit (Trinity Biotech, St. Louis, MO,
USA). Creatinine was determined in the urine and serum
samples using a modification of the Jaffe´ reaction as de-
scribed by Slot [24] and further modified by Heinegard
and Tiderstrom [25]. Creatinine clearance was calculated
from the 4-week urine and serum samples according to
the standard clearance formula C = U/S × V, where U
is the urinary concentration of creatinine, S is the con-
centration of creatinine in the serum, and V is urinary
volume in mL/min. Concentrations of total protein in the
homogenates of the renal cortex were measured with the
Pierce BCA Protein Assay (Rockford, IL, USA).
Measurement of urinary enzymes
AP was determined by measuring the conversion of
p-nitrophenylphosphate to p-nitrophenol at 410 nm in
2-week and 4-week urine samples (N = 14 and 17 rats/
treatment group, respectively). NAG concentrations in
the urine (N = 9 and 17 rats/treatment for 2-week
and 4-week urine samples, respectively) were measured
with a commercially available kit (Diazyme Laborato-
ries, San Diego, CA, USA). Urinary LDH was mea-
sured at 2 weeks (N = 12 rats/treatment group) and
4 weeks (N = 17 rats/treatment group) with the Cytotox
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96 nonradioactive cytotoxicity assay (Promega, Madison,
WI, USA). Urinary l-GST and a-GST levels were de-
termined at 2 weeks (N = 9 rats/treatment group) and
4 weeks (N = 14 rats/treatment group) with enzyme im-
munoassay kits from Biotrin International. All urinary
enzyme excretions were normalized for differences in uri-
nary creatinine excretion.
Assessment of lipid peroxidation
Lipid peroxidation was assessed by quantifying 8-
isoprostane levels in the urine (N = 4 and 10 rats/
treatment group for the 2-week and 4-week samples, re-
spectively) and lipid hydroperoxide levels in renal cortex
tissue (N = 5 rats/treatment group). A 500 lL aliquot
of urine from each rat was passed over an 8-isoprostane
affinity column (Cayman Chemical, Ann Arbor, MI,
USA), sequentially washed with 2 mL of 0.1 mol/L phos-
phate buffer and 2 mL of ultrapure water and eluted
with 2 mL of 95% ethanol. The eluted fractions were
evaporated to dryness in a 60◦C heat block under a gen-
tle stream of 100% nitrogen. Dried samples were resus-
pended in 500 lL of enzyme immunoassay (EIA) buffer
(supplied with kit) and 8-isoprostane measured with an
enzyme immunoassay kit (Cayman Chemical).
We chose to employ a direct method for estimation
of lipid hydroperoxide levels given that the traditional
methods such as MDA production and TBARS are non-
specific and have been reported to provide an unreli-
able estimate of lipid peroxidation [18–21]. To eliminate
potential interference caused by hydrogen peroxide or
endogenous ferric ions in the renal cortex, hydroper-
oxides were extracted from 500 lL of the homogenate
(described below) with deoxygenated chloroform [26].
A 500 lL aliquot of the chloroform extract was used to
quantify lipid hydroperoxide levels by measuring the con-
version of ferrous ions to ferric ions using thiocyanate as
the chromogen (Cayman Chemical). Absorbance values
were read at 500 nm with a microplate reader after trans-
ferring to a glass 96-well plate. All samples were mea-
sured in triplicate and were normalized for differences in
protein concentrations.
Renal antioxidant status
Each kidney (N = 6 rats/treatment group) was cut lon-
gitudinally slightly off-center of the sagittal plane. Re-
nal cortex was dissected from the outermost 3 mm of
the kidney perimeter on ice-cold glass plates and ho-
mogenized in an ice bath in 10 volumes of homogeniza-
tion buffer [250 mmol/L mannitol, 70 mmol/L sucrose,
1 mmol/L ethylenediaminetetraacetic acid (EDTA), ad-
justed with Tris to pH = 7.4 [27]]. Cellular debris and
nuclei were sedimented by centrifugation at 800 × g for
10 minutes. The resulting supernatant was sonicated on
ice at 50% amplitude for 30 seconds in three 10-second
intervals with a sonic dismembrator (Model 500) (Fisher
Scientific, Atlanta, GA, USA). The homogenate was
centrifuged at 20,000 × g for 10 minutes and the re-
sulting supernatant was stored at −80◦C until assayed.
SOD, catalase, GP, glutathione reductase (GR), and
GST were measured with commercially available kits
(Cayman Chemical). All antioxidant enzyme activities
of the renal cortex were normalized for protein concen-
tration of the homogenates.
Statistical analyses
All values are presented as means ± SEM and are ex-
pressed per mg protein for renal cortex enzyme activi-
ties or per mmol creatinine for urinary enzyme activities.
All data were tested for heterogeneity of variance with
the Levene median test and for normality with the
Kolmogorov-Smirnov test prior to analysis of variance
(ANOVA) [28]. When normality test failed or het-
erogeneity of variance was detected, data were rank
transformed and the ranks were subjected to one-way
ANOVA. Significant treatment effects were separated
by Student-Newman-Keuls sequential range test [28].
Product-moment (Pearson) correlation coefficients (r)
were computed between oxalate or lipid peroxidation
markers (lipid hydroperoxide and 8-isoprostane) and
markers of renal injury (AP, NAG, LDH, l-GST, and
a-GST) and renal cortical antioxidant levels with the
CORR procedures of the Statistical Analysis System
(SAS; SAS Institute, Cary, NC, USA) [29]. The corre-
lation analysis included equal numbers of rats from each
treatment and the total numbers of observations for each
correlation are shown in Table 2. Statistical differences
were declared when P ≤ 0.05.
Validation of experimental models
Since we have previously reported on urinary oxalate
excretion and renal function in the animal models used
in the present study, we reaffirmed the important char-
acteristics of these models in a subset of animals (N =
6 rats/treatment group) (see Table 1). The results ob-
tained, namely ethylene glycol–induced hyperoxaluria
and hyperoxaluria-induced renal insufficiency (as judged
by creatinine clearance) are consistent with our previous
results [22, 23, 30, 31].
RESULTS
Renal injury markers
Oxalate-induced renal injury is usually manifest by an
increased urinary excretion of renal tubular enzymes [13,
32]. To determine the degree of renal injury associated
with hyperoxaluria in HYP and HRF rats, we quantified
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Table 1. Assessment of urinary oxalate excretion and renal function in normal rats (controls), rats treated with 0.75% ethylene glycol (HYP),
unilateral nephrectomized rats, and unilateral nephrectomized rats treated with 0.75% ethylene glycol (HRF)
Control HYP Unilateral nephrectomy HRF
Oxalate
Urine lmol/24 hours
2 weeks 7.5 ± 0.9 55.5 ± 16.4a 10.9 ± 1.6 77.7 ± 10.5a
4 weeks 8.1 ± 0.5 56.0 ± 17.5a 8.9 ± 0.5 87.2 ± 6.1a
Creatinine
Urine lmol/24 hours
2 weeks 142.7 ± 23.1 163.7 ± 22.0 145.0 ± 22.1 158.4 ± 17.5
4 weeks 185.0 ± 8.8 215.5 ± 14.9 211.9 ± 10.0 175.8 ± 11.6
Serum lmol/Lb 22 ± 3 34 ± 8 22 ± 2 94 ± 8a
Clearance mL/min 3.65 ± .31 4.12 ± .29 3.25 ± .35 2.02 ± .39a
Data are presented as the means ± SEM for six rats per treatment group.
a P < 0.05 vs. control.
b Serum samples were only obtained at 4 weeks, subsequently, creatinine clearance is presented for only the 4-week data.
the urinary excretion of several enzymes considered to
be markers for such injury [33–35]. AP activity in the
urine was comparable between control and unilateral
nephrectomy and unilateral nephrectomy rats at both 2
and 4 weeks (Fig. 1A) but was modestly elevated in the
HYP rats compared to control rats while AP activity in
HRF rats was almost twofold higher than that of controls
(Fig. 1A). Urinary excretion of NAG followed a similar
pattern at 2 and 4 weeks with NAG excretion being simi-
lar between control and unilateral nephrectomy rats but
significantly elevated in both groups of hyperoxaluric rats
(Fig. 1B). Hyperoxaluria caused a significant increase in
urinary LDH activity and this increase in urinary LDH
was further accentuated in the HRF rats at both time
points (Fig. 1C).
Excretion of l-GST, although somewhat higher in HYP
rats than in control rats at 2 and 4 weeks, never attained
statistical significance (Fig. 2A). At 4 weeks, l-GST excre-
tion was higher in HRF rats than in control rats (Fig. 2A),
suggesting significant damage to the distal tubules had oc-
curred. Urinary levels of a-GST did not differ between
control and HYP rats on either collection period, but
were lower in both unilateral nephrectomy and HRF rats
after 4 weeks (Fig. 2B) indicating that a loss of renal mass
in some way alters excretion of a-GST.
Together, the above results indicate that significant re-
nal tubular injury was present in both HYP and HRF rats
and this injury was significantly correlated with urinary
oxalate excretion (Table 2).
Renal antioxidant status
Numerous studies in vitro and in vivo have demon-
strated that oxalate toxicity is accompanied by the gen-
eration of ROS in renal epithelial cells [9, 11, 12, 14, 15,
36]. Chronic exposure of renal epithelial cells to oxalate
thus imposes an oxidative stress on these cells, which,
in turn, must adapt via a number of antioxidant defense
mechanisms. In this study, the total antioxidant capacity
of the renal cortex was assessed by measuring the spe-
cific activities of the principal antioxidant enzymes: (1)
the antioxidant scavengers SOD, GP, and catalase; (2)
a detoxification enzyme, GST; and, (3) GR, an enzyme
involved in the maintenance of sufficient quantities of
reduced GSH.
Activities of SOD (Fig. 3A), catalase (Fig. 3C), and GP
(Fig. 3E) in the renal cortex were not affected by hyper-
oxaluria with activities of each antioxidant being similar
among control, HYP, and unilateral nephrectomy groups
after 4 weeks. This would suggest that neither hyperox-
aluria, nor reduced renal mass, significantly perturb the
oxidant-antioxidant balance of the renal cortex. In con-
trast, activities of SOD, catalase, and GP were attenuated
in HRF rats with the activity of each being approximately
half that in control rats. These observations suggest that
the renal cortex was under oxidative stress in the HRF
group and the antioxidant capacity was being depleted
by the sustained exposure to oxalate. GST activity did
not differ among the treatment groups (Fig. 3B) while
GR activity of the renal cortex was significantly elevated
in HRF rats (Fig. 3E) suggesting an increased demand
for reduced GSH in the HRF rats and consistent with a
pro-oxidant environment.
Lipid peroxidation
Disturbances in the pro-oxidant-antioxidant balance
may lead to oxidative damage of lipids (lipid perox-
idation) and subsequent cellular injury. Because lipid
peroxidation is thought to be a potential molecular mech-
anism by which oxalate induces renal tubule damage, we
quantified lipid peroxidation by measuring the levels of
lipid hydroperoxide in the renal cortex and levels of 8-
isoprostane in the urine to establish a possible temporal
correlation with renal damage. Urinary excretion of 8-
isoprostane was not different between control and HYP
rats (Fig. 4A), but was elevated in HRF rats compared to
unilateral nephrectomy rats after 2 weeks (Fig. 4A). Al-
though this trend was maintained at 4 weeks, the magni-
tude of the elevated excretion was significantly dampened
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Fig. 1. Urinary excretion of renal injury markers in normal rats (CON),
hyperoxaluric rats (HYP), unilateral nephrectomized rats (UNI), and
rats in renal failure induced by hyperoxaluria (HRF) after 2 and 4 weeks
on their respective treatment protocols. See the Methods section for
details on experimental models. Alkaline phosphatase (A) (N = 14 and
17 rats per treatment group at 2 and 4 weeks, respectively), N-acetyl-
b-D-glucosaminidase (B) (N = 9 and 17 rats per treatment group at 2
and 4 weeks, respectively), and lactate dehydrogenase (C) (N = 12 and
17 rats per treatment group at 2 and 4 weeks, respectively) excretion
exhibited similar patterns with levels being higher in both groups of
hyperoxaluric rats at 2 and 4 weeks. ∗P <.05 vs. control; †P <.05 vs.
unilateral nephrectomy.
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Fig. 2. Urinary excretion of l-glutathione S-transferase (l-GST) and
a-glutathione S-transferase (a-GST) in normal rats (CON), hyperox-
aluric rats (HYP), unilateral nephrectomized rats (UNI), and rats in
renal failure induced by hyperoxaluria (HRF) after 2 and 4 weeks on
their respective treatment protocols. (A) l-GST excretion tended to
be higher in HYP rats than in control rats at 2 and 4 weeks but never
attained statistical significance. l-GST excretion at 4 weeks was higher
in HRF rats than in control rats. (B) Urinary levels of a-GST were
not different between control and HYP rats after 2 and 4 weeks, but
were lower in HRF rats on each day examined. Values shown depict the
mean ± SEM for 9 and 14 rats per treatment group at 2 and 4 weeks,
respectively. ∗P <.05 vs. control; †P <.05 vs. unilateral nephrectomy.
in the HRF rats. No significant increases in renal corti-
cal content of lipid hydroperoxides were evident after
4 weeks of hyperoxaluria in either the HYP or HRF rats
(Fig. 4B). Moreover, no significant correlations were de-
tected among the renal injury markers and the indices of
lipid peroxidation (Table 2), but significant positive corre-
lations were detected for nearly all urinary enzymes and
oxalate. Together these data indicate that hyperoxaluria,
per se, is not associated with renal lipid peroxidation but
when coincident with compromised renal function may
promote oxidation of lipid molecules.
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Table 2. Correlation of renal injury markers and antioxidants with hyperoxaluria (urinary oxalate excretion) or lipid peroxidation (8-isoprostane
and lipid hydroperoxide)
Correlation coefficient
Variable Oxalate 8-isoprostane Lipid hydroperoxide
Urinary
Lactate dehydrogenase 0.648a −0.210 0.209
N-acetyl-b-D-glucosaminidase 0.567a −0.040 0.168
Alkaline phosphatase 0.678a −0.161 0.237
a-Glutathione-S-transferase −0.090 0.075 0.240
l-Glutathione-S-transferase 0.403a −0.022 0.281
Oxalate — 0.173 0.037
Renal cortex
Glutathione peroxidase −0.415b −0.091 0.016
Superoxide dismutase −0.303 0.017 −0.430
Catalase −0.668a 0.009 −0.315
Glutathione-S-transferase 0.240 −0.359 −0.040
Glutathione reductase 0.666a −0.013 −0.141
aP < 0.001; bP < 0.05. Each correlation included equal numbers of rats from each treatment group. Total number of observations for the correlations between 8
-isoprostane and each urinary enzyme (N = 40); between each renal cortical antioxidant and either oxalate or 8-isoprostane (N = 24); between oxalate and each urinary
enzyme (N = 56–68); and, between lipid hydroperoxide and all other variables (N = 20).
DISCUSSION
Numerous in vitro studies have demonstrated that ox-
alate toxicity is accompanied by the generation of ROS
in renal epithelial cells [9, 14, 17, 36–39] and the con-
comitant exposure to exogenous antioxidants attenuates
the adverse effects of oxalate [14, 36, 39]. The antioxi-
dant capacity of the renal cortex in Sprague-Dawley rats
of the present study was unaffected by hyperoxaluria,
per se, but activities of renal antioxidant enzymes were
attenuated when the oxalate load had induced some de-
gree of renal insufficiency. In contrast, Wistar rats on an
experimental regime comparable to that of the present
study had diminished levels of renal SOD after only
3 weeks on study [13]. Certainly, the lack of a signif-
icant reduction in antioxidant capacity in HYP rats of
the present study in no way precludes the importance
of free radicals in the pathogenesis of kidney stone dis-
ease, but rather underlies the complexity of redox balance
in the whole organism where metabolism, bioavailabil-
ity, and input/feedback from a multitude of systems
culminate in oxidant-antioxidant balance. Apparently,
Sprague-Dawley rats, in contrast to Wistar rats [13], react
to hyperoxaluria/crystalluria-induced oxidative stress by
maintaining normal antioxidant levels. However, when
the oxidant challenge becomes overwhelming, such as in
the case of the HRF rats, free radicals likely play a signif-
icant role, but, their production may be secondary to the
activation of other signaling pathways, such as the lipid
signaling molecules, arachidonic acid, and lysophospho-
lipids [6].
Recent in vitro studies have suggested proximal tubule
cells, when compared to distal tubule or collecting duct
cells, are more sensitive to the toxic effects of both ox-
alate and calcium oxalate but only at pathologic levels
[40–43]. Since our study was not designed to distinguish
between the effects of free oxalate ions and calcium ox-
alate crystals, it is possible that the elevation in renal in-
jury markers observed in the present study resulted from
both. Similarly, because ethylene glycol was used as the
precursor for oxalate in the present study, we cannot pre-
clude the possibility that the renal injury observed was
caused by the potentially toxic metabolites of ethylene
glycol [44]. However, we feel this is quite unlikely since
the administration of other lithogenic substances, such as
ammonium oxalate and hydroxyproline, also results in
renal injury [32]. Nevertheless, hyperoxaluria increased
urinary excretion of AP, NAG, and LDH in both HYP
and HRF rats relative to control and unilateral nephrec-
tomy rats, thus substantiating previous results [11, 12, 32].
Although renal injury markers were elevated in rats with
hyperoxaluria, there was no coincident change in antioxi-
dant status or elevation in lipid peroxidation as judged by
either urinary 8-isoprostane excretion or cortical content
of lipid hydroperoxides. This lack of correlation would
suggest that lipid peroxidation, per se, is not necessar-
ily responsible for the renal damage that is seen under
conditions of mild hyperoxaluria. In support of this no-
tion, Gutteridge and Halliwell [19] recently concluded
that most toxins acting by free radical mechanisms do
not act primarily via lipid peroxidation and that oxidative
damage to DNA and protein is often more important.
Contrary to the results of the present study, previ-
ous work using various experimental animal models has
demonstrated lipid peroxidation does play a significant
role in calcium oxalate nephrolithiasis [5, 7, 10–13]. More-
over, lipid peroxidation correlated with urinary oxalate
levels and urinary tubular enzymes (a-GST, NAG, and
b-galactosidase) in patients with kidney stones [16]. No
such correlations were detected in the present study. We
offer several possible explanations for these discrepan-
cies. First, previous studies have quantified lipid peroxi-
dation indirectly as MDA and TBARS. The assays used to
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Fig. 3. Antioxidant status of the renal cortex in normal rats (CON), hyperoxaluric rats (HYP), unilateral nephrectomized rats (UNI) and rats
in renal failure induced by hyperoxaluria (HRF) after 4 weeks on their respective treatment protocols. See the Methods section for details on
experimental models. Values shown depict the mean ± SEM for six rats for each treatment group. (A) Superoxide dismutase (SOD) activity was
similar between control and HYP rats, but was lower in HRF rats. (B) Glutathione-S-transferase (GST) activity did not differ among the treatment
groups. (C) Catalase activity was not affected by HYP, but was significantly attenuated in HRF rats. (D) Glutathione reductase (GR) activity in
the renal cortex of HRF rats was elevated compared to all other groups. (E) Glutathione peroxidase activity was similar between control and HYP
rats, but was attenuated in HRF rats. ∗P <.05 vs. control.
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Fig. 4. Assessment of lipid peroxidation in normal rats (CON), hyper-
oxaluric rats (HYP), unilateral nephrectomized rats (UNI), and rats in
renal failure induced by hyperoxaluria (HRF) after 2 and 4 weeks on
their respective treatment protocols. See the Methods section for details
on experimental models. (A) Urinary excretion of 8-isoprostane after 2
(N = 4 rats/group) and 4 weeks (N = 10 rats/group) on treatment. HYP
rats exhibited normal patterns of 8-isoprostane excretion after 2 and
4 weeks while excretion in HRF rats was elevated compared to their
appropriate control group (i.e., the unilateral nephrectomy rats). (B)
Lipid hydroperoxide content of the renal cortex after 4 weeks (N = 5
rats/group). No significant changes in lipid hydroperoxide content were
detected among treatment groups after 4 weeks. ∗P <.05 vs. control;
†P <.05 vs. unilateral nephrectomy.
measure both of these compounds each possess a number
of inherent limitations which can lead to erroneous con-
clusions since most TBARS in body fluids are not related
to lipid peroxidation (for reviews see [18–21]). A further
confounding factor is that most of the aforementioned in
vivo studies have generated hyperoxaluria by the provi-
sion of ethylene glycol. Glycoaldehyde, an intermediate
of ethylene glycol metabolism, is a known nonlipid source
of TBARS [20]. Gutteridge and Halliwell [19] concluded
these tests were an unreliable index of levels of lipid per-
oxidation in cells, tissues, or body fluids. Although no
“ideal” marker for lipid peroxidation currently exists,
measurement of urinary 8-isoprostane provides an inte-
grated assessment of lipid peroxidation and is generally
considered the best available biomarker [45, 46]. To our
knowledge, this is the first report of urinary 8-isoprostane
levels in an experimental animal model of hyperoxaluria.
Basal levels of 8-isoprostane excretion (approximately
4 ng/day) measured in the current study closely approxi-
mate what others have reported for Sprague-Dawley rats
of comparable age and weight [47, 48]. The absence of an
increase in renal cortical content of lipid hydroperoxides
in response to hyperoxaluria also lends further support
to a lack of lipid peroxidation in rats of the current study.
A second plausible explanation for the disparities be-
tween previous studies and the current study may be at-
tributable to the particular strain of rat that was used.
Cruzan et al [49] reported significant strain differences
exist with respect to sensitivity to ethylene glycol and its
metabolites, including oxalate. Curiously, rats that are ap-
parently more sensitive to ethylene glycol (i.e., the Wistar
strain) are also the strain of rats that responds to a chal-
lenge of ethylene glycol with a greater than 50-fold in-
crease in urinary excretion of l-GST, a distal tubule injury
marker [13]. In Sprague-Dawley rats, the increased excre-
tion of l-GST was not nearly as pronounced even after
4 weeks of hyperoxaluria (present study). It is also note-
worthy that Wistar rats have calcium oxalate crystal depo-
sition in renal tissues within 5 to 7 days of ethylene glycol
treatment [11–13], while the same experimental regime
does not produce crystals in Sprague-Dawley rats until
10 to 14 days of treatment [10, 32]. Furthermore, as dis-
cussed earlier, attenuation of the renal antioxidant capac-
ity in response to hyperoxaluria is evident by 3 weeks in
Wistar rats [13], whereas no such changes were detected
in Sprague-Dawley rats after 4 weeks (present study).
Whether the Sprague-Dawley strain of rats is less sensi-
tive to the toxic effects of oxalate than the Wistar strain
remains speculative, but the several lines of experimen-
tal evidence discussed above suggests it is an intriguing
possibility.
Finally, significant differences among the body weights
(and presumably age) of the rats utilized in the cur-
rent study and previous reports may account for the ap-
parently different results. Although no clear correlation
between renal antioxidant capacity and age has been es-
tablished in the rat [27], younger rats (relative to those
of the current study) of both the Sprague-Dawley (150 to
160 g) and the Wistar (180 g) strains were shown to have
increased levels of urinary and renal lipid peroxides (mea-
sured as MDA) as well as attenuated renal antioxidant
levels in response to ethylene glycol–induced hyperox-
aluria [10, 13]. However, age/weight alone cannot entirely
account for differing results among the studies since sub-
sequent studies by Huang et al [11] reported a significant
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elevation in both urinary MDA and urinary TBARS in
hyperoxaluric Wistar rats weighing approximately 300 g,
a body weight similar to that of rats in the present study.
Certainly, the dichotomy of results among the studies em-
phasizes the need for a large comprehensive study which
includes both strains of rats at various ages with a side-
by-side comparison of various assay methodologies (i.e.,
TBARS or MDA vs. 8-isoprostane). Despite the criticism
of the reliability of the MDA and TBARS assays in bio-
logic samples [18–21], a recent report demonstrated that
the results from the urinary MDA assay closely paralleled
those of urinary 8-isoprostane in a different rat renal dis-
ease model [50], thus, assessment of lipid peroxidation
by the MDA assay may not necessarily be completely
unreliable.
CONCLUSION
The results from the present study suggest that experi-
mental hyperoxaluria induced by ethylene glycol results
in elevated renal injury markers (enzymuria) without any
detectable signs of oxidative stress. However, when the
hyperoxaluria is coincident with impaired renal func-
tion, the antioxidant capacity of the renal cortex be-
comes compromised. Alternatively, in the rat model of
hyperoxaluria-induced renal failure (HRF), renal tissue
may have been exposed to higher levels of oxalate and
it is possible, perhaps, that some threshold level needs to
be achieved for oxidative stress to ensue. Nevertheless,
the attenuation in the antioxidant capacity of the renal
cortex in HRF rats did not appear to be severe enough
for oxidative damage to occur because lipid peroxidation
remained normal after 4 weeks. These results suggest that
oxidation of proteins and/or DNA by ROS could play a
more significant role than lipid peroxidation in the patho-
genesis of kidney stone disease.
We conclude that although lipid peroxidation may play
an important role in the progression of calcium oxalate
stone disease, it does not appear to be the underlying
mechanism by which oxalate and/or calcium oxalate in-
duces renal injury, as markers of renal injury are elevated
significantly before antioxidant capacity is diminished or
lipid peroxidation is detected. This would suggest that
lipid peroxidation may be a consequence of oxalate me-
diated renal tubular injury rather than the initiating cause.
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